Neural Cell News 12.14 April 11, 2018 | |
| |
TOP STORY‘Sleeping’ Stem Cells Could Aid Regenerative Medicine for Brain Repair Scientists identified a new type of stem cell in the brain which they say has a high potential for repair following brain injury or disease. [Press release from the University of Cambridge discussing online prepublication in Science] Press Release | Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Using human neurons derived from induced pluripotent stem cells (iPSCs) that expressed apolipoprotein E4 (ApoE4), a variant of the APOE gene product and the major genetic risk factor for Alzheimer’s disease, the authors demonstrated that ApoE4-expressing neurons had higher levels of tau phosphorylation, unrelated to their increased production of amyloid-β peptides, and that they displayed GABAergic neuron degeneration. [Nat Med] Abstract | Press Release | Editorial Human Hippocampal Neurogenesis Persists throughout Aging Scientists found similar numbers of intermediate neural progenitors and thousands of immature neurons in the dentate gyrus (DG), comparable numbers of glia and mature granule neurons, and equivalent DG volume across ages. Nevertheless, older individuals had less angiogenesis and neuroplasticity and a smaller quiescent progenitor pool in anterior-mid DG, with no changes in posterior DG. [Cell Stem Cell] Full Article | Press Release | Graphical Abstract The authors interrogated reciprocal signaling between glioblastoma stem cells (GSCs) and their differentiated glioblastoma cell (DGC) progeny. They found that DGCs accelerated GSC tumor growth. [Cell Stem Cell] Abstract | Graphical Abstract Investigators identified glycogen-synthase kinase 3β (GSK3β) and voltage-gated Na+ channel Nav1.6 as regulators of neuroplasticity induced by environmentally enriched or isolated conditions—models for resilience and vulnerability. [Cell Rep] Full Article | Graphical Abstract Scientists used a genome-wide loss-of-function screen for factors limiting axonal regeneration from cerebral cortical neurons in vitro. [Cell Rep] Full Article | Graphical Abstract Researchers showed that interleukin-6 (IL-6) promotes proliferation of post-natal murine forebrain neural stem cells (NSCs) and that, when the IL-6 receptor is inducibly knocked out in post-natal or adult neural precursors, this causes a long-term decrease in forebrain NSCs. [Stem Cell Reports] Full Article | Graphical Abstract Scientists generated striatal progenitors from human pluripotent stem cells (hPSCs) within a fully defined and scalable PNIPAAm-PEG 3D hydrogel. Transplantation of 3D-derived striatal progenitors into a transgenic mouse model of Huntington disease slowed disease progression, improved motor coordination, and increased survival. [Stem Cell Reports] Full Article Effects of 3D Culturing Conditions on the Transcriptomic Profile of Stem-Cell-Derived Neurons Investigators report the characterization of the effects of different culturing conditions on the transcriptomic profiles of induced neuronal cells and developed a method for the rapid generation of 3D co-cultures of neuronal and astrocytic cells from the same pool of human embryonic stem cells. [Nat Biomed Eng] Abstract Scientists investigated the effect of tumor necrosis factor-alpha (TNF-α) pretreatment on human neural progenitor cells (hNPCs) under ischemia-related conditions in vitro. hNPCs harvested from fetal brain tissue were pretreated with TNF-α before being subjected to oxygen–glucose deprivation to mimic ischemia in vitro. [Mol Med] Full Article MicroRNA‐29a Regulates Neural Stem Cell Neuronal Differentiation by Targeting PTEN The authors showed that the expression of miR‐29a was upregulated during neural stem cells (NSCs) differentiation, while the expression of PTEN was downregulated during NSC differentiation. [J Cell Biochem] Abstract | |
| |
REVIEWSNeurovascular Communication during CNS Development Scientists review the current knowledge on how neurons in particular influence growing blood vessels during CNS development and on how vessels participate in shaping the neural compartment. [Dev Cell] Abstract Proteostasis in Huntington’s Disease: Disease Mechanisms and Therapeutic Opportunities Unravelling the molecular mechanisms involved in Huntington’s disease (HD) pathogenesis of proteostasis provides new insight in disease progression in HD as well as possible therapeutic avenues. Recent developments of potential therapeutics are discussed. [Acta Pharmacol Sin] Abstract Visit our reviews page to see a complete list of reviews in the neural cell research field. | |
| |
INDUSTRY NEWSHouston Methodist Leads International Clinical Research for Rare Neurodegenerative Disorder Spinocerebellar ataxia (SCA) is characterized by degeneration of the brain and spinal cord with progressive clumsiness and balance difficulties typically leading to total disability and death. The $6 million, five-year clinical trial readiness grant awarded to Houston Methodist and led by Tetsuo Ashizawa, MD., will focus on several anticipated investigational therapies for SCA1 and SCA3. [Houston Methodist Hospital] Press Release UTHealth Neurologists Awarded NIH Grants to Explore Causes of Brain Bleeds, Dementia Researchers at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) have been awarded grants from the National Institutes of Health (NIH) to explore how the buildup of protein deposits in the brain can trigger dementia and stroke. [Texas Medical Center] Press Release £2.4M Boost for Brain Tumor Research Scientists at Edinburgh are to receive £2.4 million to find new ways to tackle brain tumors. The funding from leading charity Cancer Research UK will help researchers to understand more about how to target tumors with drugs. [University of Edinburgh] Press Release Amylyx Pharmaceuticals, Inc., in collaboration with The ALS Association, ALS Finding a Cure®, the Northeast ALS Consortium, and the Massachusetts General Hospital Neurological Clinical Research Institute, announced that the first patients to complete the CENTAUR Phase II clinical trial have elected to continue treatment in an open label extension study of AMX0035. [Amylyx Pharmaceuticals, Inc.] Press Release Therapix Biosciences Ltd. announced topline results from its investigator-initiated Phase IIa study at Yale University, suggesting that THX-110 and palmitoylethanolamide significantly improved symptoms over time in adult subjects with Tourette syndrome. [Therapix Biosciences Ltd.] Press Release Novartis Drug Afinitor DISPERZ® Receives FDA Approval to Treat TSC-Associated Partial-Onset Seizures Novartis announced that the FDA has approved Afinitor DISPERZ®, for the adjunctive treatment of adult and pediatric patients aged two years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures. [Novartis (PR Newswire Association LLC.)] Press Release | |
| |
POLICY NEWSBeijing Launches Pioneering Brain-Science Centre Beijing has announced plans to build a brain-science centre that will rival in size some of the world’s largest neuroscience organizations. It will also serve as a core facility for the country’s long-awaited brain project — China’s version of the high-profile brain-science initiatives under way elsewhere in the world. [Nature News] Editorial Web of Science Owner Buys Tool that Offers One-Click Access to Journal Articles The owner of the large scholarly search engine Web of Science — Clarivate Analytics — has bought a start-up company whose tool gives researchers one-click, legal access to journal articles even when off campus. [Nature News] Editorial India Creates Unique Tiered System to Punish Plagiarism The Indian government has adopted its first regulations on academic plagiarism—rules that some researchers say are too lenient and others fear go too far and will be difficult to implement. [ScienceInsider] Editorial Got Data? Survey of 2017 March for Science Doesn’t Make the Grade A group of researchers has released the first results of a large survey of those who participated in and supported last year’s March for Science. Some social scientists say the analysis is fundamentally flawed and reflects poorly on an organization that champions scientific rigor. [ScienceInsider] Editorial
| |
EVENTSNEW Cold Spring Harbor (CSH): Mouse Development, Stem Cells & Cancer Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Brain Disorders (New York Medical College) Postdoctoral Biologist – Neural Cell (University of Oxford) Research Fellow/Associate – Neuroscience and Diabetes (Rutgers University) Postdoctoral Position – Bacterial Virulence Factors (University of California, Irvine) Postdoctoral Fellow – Neural Control of Circulation (MD Anderson Cancer Center) Postdoctoral Position – Cancer, Immunotherapy, and Fibrosis (University of Alabama at Birmingham) Scientist – Molecular Neuroscience (Loyola University Chicago) Postdoctoral Associate – hiPSC-Based Brain Organoids (Rutgers University) Postdoctoral Position – Neuroscience and Mitochondrial Physiology (University of Moncton) Postdoctoral Position – Pain in Mouse Models of Spinal Cord Injury (Indiana University) Postdoctoral Position – Spinal Cord Injury (Nanyang Technological University) Multiple Faculty Positions – Neuroscience and Neuroengineering (Tsinghua University) Faculty Members – Neuroscience (Mercer University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Neural Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|